
|Articles|February 6, 2023
POLL: Are You Attending South Beach Symposium?
Author(s)Dermatology Times Staff
Listen
0:00 / 0:00
Key Takeaways
- Personalized treatment strategies have advanced the management of lung cancer brain metastases, improving patient outcomes.
- Targeted therapies and immunotherapies offer new hope, with molecular profiling and advanced imaging enabling precise treatment planning.
Click here to answer this week's poll.
Advertisement
Are You Attending South Beach Symposium?
If you can't attend South Beach Symposium,
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
Expert Panel Unanimously Backs DecisionDx-Melanoma for Guiding Personalized Cancer Care
4
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
5

















